Nektar Therapeutics (NKTR) — Cash Flow-to-Debt Ratio
Nektar Therapeutics (NKTR) has a Cash Flow-to-Debt Ratio of -0.24x as of March 2026, meaning its operating cash flow of $-44.30 Million could theoretically repay 0% of its total liabilities ($187.06 Million) in one year. See NKTR FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nektar Therapeutics Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Nektar Therapeutics across 32 annual periods. Also explore how fast is Nektar Therapeutics growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nektar Therapeutics (1994–2025)
Year-by-year debt coverage analysis for Nektar Therapeutics. For market capitalisation and broader financial context, see NKTR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.09x | $-208.51 Million | $190.57 Million | ▼ -51.4% |
| 2024 | -0.72x | $-175.71 Million | $243.11 Million | ▼ -0.2% |
| 2023 | -0.72x | $-192.61 Million | $267.05 Million | ▲ +18.4% |
| 2022 | -0.88x | $-304.01 Million | $343.96 Million | ▲ +6.3% |
| 2021 | -0.94x | $-412.66 Million | $437.68 Million | ▼ -38.9% |
| 2020 | -0.68x | $-313.29 Million | $461.47 Million | ▼ -18.1% |
| 2019 | -0.57x | $-328.68 Million | $571.97 Million | ▼ -134.6% |
| 2018 | 1.66x | $718.21 Million | $432.60 Million | ▲ +969.3% |
| 2017 | -0.19x | $-80.41 Million | $421.04 Million | ▲ +21.5% |
| 2016 | -0.24x | $-117.02 Million | $480.75 Million | ▼ -65.1% |
| 2015 | -0.15x | $-73.08 Million | $495.63 Million | ▲ +57.9% |
| 2014 | -0.35x | $-142.01 Million | $405.29 Million | ▼ -376.9% |
| 2013 | -0.07x | $-38.53 Million | $524.43 Million | ▲ +74.5% |
| 2012 | -0.29x | $-129.76 Million | $450.77 Million | ▼ -3.4% |
| 2011 | -0.28x | $-113.74 Million | $408.74 Million | ▼ -114.4% |
| 2010 | -0.13x | $-55.87 Million | $430.56 Million | ▼ -254.5% |
| 2009 | 0.08x | $39.74 Million | $473.15 Million | ▲ +121.3% |
| 2008 | -0.39x | $-145.78 Million | $370.38 Million | ▼ -237.4% |
| 2007 | 0.29x | $146.30 Million | $510.66 Million | ▲ +267.2% |
| 2006 | -0.17x | $-92.72 Million | $541.12 Million | ▼ -16.8% |
| 2005 | -0.15x | $-78.00 Million | $531.74 Million | ▲ +47.9% |
| 2004 | -0.28x | $-78.14 Million | $277.58 Million | ▼ -67.2% |
| 2003 | -0.17x | $-76.20 Million | $452.60 Million | ▲ +10.2% |
| 2002 | -0.19x | $-74.97 Million | $399.87 Million | ▼ -46.6% |
| 2001 | -0.13x | $-50.77 Million | $396.93 Million | ▼ -25.9% |
| 2000 | -0.10x | $-35.74 Million | $351.66 Million | ▲ +7.1% |
| 1999 | -0.11x | $-15.33 Million | $140.18 Million | ▲ +89.4% |
| 1998 | -1.03x | $-19.22 Million | $18.61 Million | ▼ -570.2% |
| 1997 | 0.22x | $4.98 Million | $22.67 Million | ▲ +124.2% |
| 1996 | -0.91x | $-5.80 Million | $6.40 Million | ▲ +48.7% |
| 1995 | -1.77x | $-5.30 Million | $3.00 Million | ▲ +20.5% |
| 1994 | -2.22x | $-4.00 Million | $1.80 Million | — |